Bhargav Vyas
About Bhargav Vyas
Data last updated:
Bhargav Vyas is a Director at Monash Biotech Private Limited (since 2018) and Director at Genesis Embryology Private Limited (since 2022). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.10 Cr; the largest is Monash Biotech Private Limited at ₹95.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Monash Biotech Private Limited U33100GJ2018PTC103856 | Director | 04 Sep 2018 | 2018 | ₹95.8 Lakh (FY 2025) | Active |
 Genesis Embryology Private Limited U85110GJ2014PTC080143 | Director | 25 Aug 2022 | 2014 | ₹13.8 Lakh (FY 2025) | Active |
Board colleagues of Bhargav Vyas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paul John Verma | 02588376 | Monash Biotech Private Limited , Genesis Embryology Private Limited | Director |
| Shobhan Ratilal Vyas | 02466938 | Monash Biotech Private Limited , Genesis Embryology Private Limited | Director |
| William Alexander Ritchie | 02604481 | Monash Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhargav Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhargav Vyas
Bhargav Vyas currently holds 2 directorships: Monash Biotech Private Limited (Director, since 04 Sep 2018, revenue ₹95.8 Lakh (FY 2025)); Genesis Embryology Private Limited (Director, since 25 Aug 2022, revenue ₹13.8 Lakh (FY 2025)).
Bhargav Vyas was first appointed on 04 Sep 2018 as Director at Monash Biotech Private Limited. The most recent appointment on record is 25 Aug 2022 at Genesis Embryology Private Limited.
The 2 current companies of Bhargav Vyas that report revenue have a combined latest revenue of ₹1.10 Cr: Monash Biotech Private Limited ₹95.8 Lakh (FY 2025); Genesis Embryology Private Limited ₹13.8 Lakh (FY 2025).
The current boards of Bhargav Vyas's companies include Paul John Verma (Monash Biotech Private Limited), Shobhan Ratilal Vyas (Monash Biotech Private Limited), William Alexander Ritchie (Monash Biotech Private Limited).